These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reduction of plasma gonadotropin levels and pituitary tumor size by treatment with bromocriptine in a patient with gonadotropinoma. Yamakita N; Komaki T; Murai T; Kawamura S Intern Med; 1999 Mar; 38(3):266-71. PubMed ID: 10337939 [TBL] [Abstract][Full Text] [Related]
4. Ovarian hyperstimulation syndrome caused by pituitary gonadotroph adenoma secreting follicle-stimulating hormone. Ghayuri M; Liu JH Obstet Gynecol; 2007 Feb; 109(2 Pt2):547-9. PubMed ID: 17267890 [TBL] [Abstract][Full Text] [Related]
5. Identification of a silent pituitary somatotropic adenoma based on a paradoxic response of growth hormone on a thyrotropin-releasing hormone or gonadotropin-releasing hormone provocation test. Matsuno A; Ogino Y; Katayama H; Osamura RY; Nagashima T Am J Obstet Gynecol; 2001 Feb; 184(3):286-8. PubMed ID: 11228475 [TBL] [Abstract][Full Text] [Related]
17. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. Kwekkeboom DJ; de Jong FH; Lamberts SW J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356 [TBL] [Abstract][Full Text] [Related]
18. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365 [TBL] [Abstract][Full Text] [Related]